AG
XLRN
Artal Group’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,000,000
| Closed | -$172M | – | 159 |
|
|
2021
Q3 | $172M | Sell |
1,000,000
-400,000
| -29% | -$68.8M | 3.85% | 6 |
|
|
2021
Q2 | $176M | Hold |
1,400,000
| – | – | 3.57% | 5 |
|
|
2021
Q1 | $190M | Hold |
1,400,000
| – | – | 3.35% | 5 |
|
|
2020
Q4 | $179M | Hold |
1,400,000
| – | – | 3.85% | 5 |
|
|
2020
Q3 | $158M | Hold |
1,400,000
| – | – | 3.82% | 3 |
|
|
2020
Q2 | $133M | Sell |
1,400,000
-100,000
| -7% | -$9.53M | 3.73% | 4 |
|
|
2020
Q1 | $135M | Buy |
1,500,000
+300,000
| +25% | +$27M | 5.7% | 2 |
|
|
2019
Q4 | $63.6M | Sell |
1,200,000
-300,000
| -20% | -$15.9M | 2.46% | 9 |
|
|
2019
Q3 | $59.3M | Hold |
1,500,000
| – | – | 2.38% | 8 |
|
|
2019
Q2 | $61.6M | Sell |
1,500,000
-150,000
| -9% | -$6.16M | 2.49% | 9 |
|
|
2019
Q1 | $76.8M | Buy |
1,650,000
+600,000
| +57% | +$27.9M | 3.14% | 5 |
|
|
2018
Q4 | $45.7M | Buy |
1,050,000
+50,000
| +5% | +$2.18M | 1.69% | 8 |
|
|
2018
Q3 | $57.2M | Hold |
1,000,000
| – | – | 1.49% | 6 |
|
|
2018
Q2 | $48.5M | Buy |
1,000,000
+150,000
| +18% | +$7.28M | 1.03% | 5 |
|
|
2018
Q1 | $33.2M | Buy |
850,000
+100,000
| +13% | +$3.91M | 0.42% | 12 |
|
|
2017
Q4 | $31.8M | Buy |
750,000
+50,000
| +7% | +$2.12M | 0.48% | 6 |
|
|
2017
Q3 | $26.1M | Hold |
700,000
| – | – | 0.45% | 8 |
|
|
2017
Q2 | $21.3M | Sell |
700,000
-50,000
| -7% | -$1.52M | 0.37% | 12 |
|
|
2017
Q1 | $19.9M | Buy |
750,000
+600,000
| +400% | +$15.9M | 0.44% | 11 |
|
|
2016
Q4 | $3.83M | Sell |
150,000
-25,000
| -14% | -$638K | 0.09% | 33 |
|
|
2016
Q3 | $6.33M | Buy |
175,000
+75,000
| +75% | +$2.71M | 0.13% | 27 |
|
|
2016
Q2 | $3.4M | Buy |
+100,000
| New | +$3.4M | 0.07% | 36 |
|